Tag: medresearch

Home medresearch
Post

No cardiologists available in half of US counties as study reveals ‘incredibly concerning’ care gaps

Nearly half of all U.S. counties don’t have a practicing cardiologist on staff, according to a recent study published in the Journal of the American College of Cardiology (JACC). Rural communities are most affected, with Americans in those areas dying earlier and more often from heart disease that could have been prevented, according to a...

Post

Mechanical artificial heart is using high-speed rail tech to keep patients alive

In a groundbreaking medical achievement, the first fully mechanical heart developed by BiVACOR has been successfully implanted in a human patient. This milestone marks a significant advancement in the field of cardiac care, offering new hope for those awaiting heart transplants. GET SECURITY ALERTS, EXPERT TIPS – SIGN UP FOR KURT’S NEWSLETTER – THE CYBERGUY...

Post

High blood pressure and Alzheimer’s disease could go hand in hand, study finds

The risk of Alzheimer’s disease could escalate along with high blood pressure, according to a new study. Published in the medical journal Neurology, the research found that people age 60 and older who have untreated high blood pressure may be more likely to develop the common dementia type. Although the results don’t prove that untreated...

Post

Men’s cancer deaths expected to spike more than 90% by 2050, study finds

The prevalence of cancer among men is expected to skyrocket globally in the coming decades, according to a new study from the American Cancer Society (ACS). To predict future risk, Australian researchers analyzed the mortality rates tied to 30 different types of cancer among adult men in 2022, based on data from the International Agency...

Post

Top 10 causes of death in the US, see the CDC’s latest list

The U.S. Centers for Disease Control and Prevention (CDC) has released the biggest causes of mortality in 2023. The report, published by the agency on Aug. 8, was based on death records from the National Vital Statistics System. A total of 3,090,582 deaths occurred in the U.S. in 2023, a decline of 6.1% compared to...

Post

Endometrial cancer patients see new hope as FDA approves 'transforming' immunotherapy drug

The U.S. Food and Drug Administration (FDA) has approved a new drug for certain adult patients with endometrial cancer. Jemperli (dostarlimab-gxly) — made by British pharmaceutical company GSK — is intended for people with primary advanced or recurrent forms of the cancer, according to the FDA’s Aug. 1 announcement. It is an immunotherapy-based drug, which...